Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Preventing Structural Damage in Early Psoriatic Arthritis — Stella

Home/Psoriatic Arthritis (PsA)/Preventing Structural Damage in Early Psoriatic Arthritis

View on ClinicalTrials.gov

Recruiting

Back to Psoriatic Arthritis (PsA) trials

Preventing Structural Damage in Early Psoriatic Arthritis

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Hong Kong

The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong

Key details

Phase

Post-approval study

Sponsor

Chinese University of Hong Kong

Enrollment target

~108 participants

Started

March 2026

Primary completion

December 2027

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.